Skip to main content
Log in

Hereditary hemorrhagic telangiectasia: how to efficiently detect hepatic abnormalities using ultrasonography

  • Review Article–Gastroenterology
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

Introduction

Hereditary hemorrhagic telangiectasia (HHT) is a multiorgan genetic angiodysplastic affection characterized by visceral vascular malformations. It affects mainly the brains, lungs, gastrointestinal tract, and nasal mucosa. Unlike those organs, hepatic involvement, although very frequently occurring, is insufficiently recognized, mainly because of the complex vascular structure of this organ. Thus, treating HHT patients requires a solid understanding of these hepatic anomalies. It is especially important for any general clinicians to be able to recognize clinical findings in HHT, which leads to a high suspicion of HHT and have an index of suspicion for liver abnormalities of HHT. For this purpose, keen awareness of clinical as well as hepatic sonographic (US) findings is paramount.

Aim

The aim of this review is to summarize previously reported findings on the hepatic US through a thorough analysis of related articles, and to (a) determine the role of US in the diagnosis of hepatic involvement in HHT patients and (b) propose the most simple and easy way to detect HHT-related abnormalities during routine US examinations.

Conclusion

Hepatic US serves to diagnose the detailed complex hepatic changes typical of HHT, and contributes to increased diagnostic confidence of hepatic changes in HHT patients, with the most simple way not to overlook HHT-related abnormalities being to find hepatic artery dilatation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

US:

Ultrasonography

HHT:

Hereditary hemorrhagic telangiectasia

AV shunt:

Arteriovenous shunt

AP shunt:

Arterioportal shunt

PV shunt:

Portovenous shunt

VVshunt:

Venovenous shunt

AVM:

Arteriovenous malformation

SMI:

Superb microvascular imaging

References

  1. Naganuma H, Ishida H, Niizawa M, et al. Hepatic involvement in Osler–Weber–Rendu disease: findings on pulsed and color Doppler sonography. AJR Am J Roentgenol. 1995;165:1421–5.

    PubMed  CAS  Google Scholar 

  2. Gelin J, Wilms G. Angiodysplasia of the liver and gastrointestinal system in Rendu–Osler–Weber disease. Rofo. 1985;143:722–4.

    PubMed  CAS  Google Scholar 

  3. Buscarini E, Danesino C, Olivieri C, Lupinacci G, Zambelli A. Liver involvement in hereditary haemorrhagic telangiectasia or Rendu–Osler–Weber disease. Dig Liver Dis. 2005;37:635–45.

    PubMed  CAS  Google Scholar 

  4. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995;333:918–24.

    PubMed  CAS  Google Scholar 

  5. Govani FS, Sovlin CL. Hereditary hemorrhagic telangiectasia:a clinical and scientific review. Eur J Hum Gen. 2009;17:860–71.

    CAS  Google Scholar 

  6. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome). Am J Med Genet. 2000;91:66–7.

    CAS  Google Scholar 

  7. Schelker RC, Barreiros AP, Hart C, et al. Macro-and microcirculation patterns of intrahepatic blood flow changes in patients with hereditary hemorrhagic telangiectasia. World J Gastroenterol. 2017;23:486–95.

    PubMed  PubMed Central  Google Scholar 

  8. Shovlin CL, Hughes JMB, Tuddenham EGD, et al. A gene for hereditary hemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994;6:205–9.

    PubMed  CAS  Google Scholar 

  9. Ralls PW, Johnson MB, Radin DR, et al. Hereditary hemorrhagic telangiectasia: findings in the liver with color Doppler sonography. AJR Am J Roentgenol. 1992;159:59–61.

    PubMed  CAS  Google Scholar 

  10. Bernard G, Mion F, Henry L, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology. 1993;105:482–7.

    PubMed  CAS  Google Scholar 

  11. Bross DA, Perez-Atayde A, Mandell VS, et al. Hereditary hemorrhagic telangiectasia presenting in early childhood. J Pediatr Gastroenterol Nutr. 1994;18:497–500.

    PubMed  CAS  Google Scholar 

  12. Hagspiel KD, Christ ER, Schöpke W. Hereditary hemorrhagic telangiectasis (Osler–Rendu–Weber disease) with pulmonary, hepatic and renal disease pattern. Rofo. 1995;163:190–2.

    PubMed  CAS  Google Scholar 

  13. Ozdemir H, Ilgit ET, Konus O, et al. Hepatic color Doppler sonography for hereditary hemorrhagic telangiectasia. Abdom Imaging. 1996;21:501–3.

    PubMed  CAS  Google Scholar 

  14. Buscarini E, Buscarini L, Danesino C, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol. 1997;26:111–8.

    PubMed  CAS  Google Scholar 

  15. McInroy B, Zajko AB, Pinna AD. Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol. 1998;170:413–5.

    PubMed  CAS  Google Scholar 

  16. Vilgrain V, Lebrec D. Images in hepatology. Hepatic pseudotumor in Osler–Weber–Rendu disease. J Hepatol. 1998;28:343.

    PubMed  CAS  Google Scholar 

  17. Naganuma H, Ishida H, Konno K, et al. Intrahepatic venous collaterals. Abdom Imaging. 1998;23:166–71.

    PubMed  CAS  Google Scholar 

  18. Weik C, Greiner L. The liver in hereditary hemorrhagic telangiectasia (Weber–Rendu–Osler disease). Scand J Gastroenterol. 1999;34:1241–6.

    PubMed  CAS  Google Scholar 

  19. Weik C, Johanns W, Janssen J, et al. The liver and hereditary hemorrhagic telangiectasia. Z Gastroenterol. 2000;38:31–7.

    PubMed  CAS  Google Scholar 

  20. Chou YH, Tiu CM, Hsu CC, et al. Hereditary haemorrhagic telangiectasia: hepatic lesions demonstrated with colour Doppler and power Doppler sonography. Eur J Radiol. 2000;34:52–6.

    PubMed  CAS  Google Scholar 

  21. Grudeva-Popova JG, Vakrilov VA, et al. Pulmonary, gastrointestinal and liver vascular malformations in Rendu–Osler disease. Folia Med (Plovdiv). 2000;42:60–3.

    CAS  Google Scholar 

  22. Woolley S, Zellweger U. Liver changes in telangiectasia hemorrhagica hereditaria (Osler disease). Schweiz Med Wochenschr. 2000;130:671.

    PubMed  CAS  Google Scholar 

  23. Matsuo M, Kanematsu M, Kato H, et al. Osler–Weber–Rendu disease: visualizing portovenous shunting with three-dimensional sonography. AJR Am J Roentgenol. 2001;176:919–20.

    PubMed  CAS  Google Scholar 

  24. Pfitzmann R, Heise M, Langrehr JM, et al. Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. Transplantation. 2001;72:237–41.

    PubMed  CAS  Google Scholar 

  25. Caselitz M, Chavan A, Manns MP, et al. Hereditary hemorrhagic telangiectasia (Osler–Rendu–Weber disease) and its manifestation in the liver. Z Gastroenterol. 2001;39:533–42.

    PubMed  CAS  Google Scholar 

  26. Amaris J, Duclos-Vallée JC, Bletry O, et al. Hereditary hemorrhagic telangiectasias with liver involvement and high cardiac output. Liver Transpl. 2001;7:824–5.

    PubMed  CAS  Google Scholar 

  27. Bodner G, Peer S, Karner M, et al. Nontumorous vascular malformations in the liver: color Doppler ultrasonographic findings. J Ultrasound Med. 2002;21:187–97.

    PubMed  Google Scholar 

  28. Geisthoff UW, Schneider G, Fischinger J, et al. Hereditary hemorrhagic telangiectasia (Osler's disease). An interdisciplinary challenge. HNO. 2002;50:114–28.

    PubMed  CAS  Google Scholar 

  29. Hatzidakis AA, Gogas C, Papanikolaou N, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber disease). Eur Radiol. 2002;12:S51–S5555.

    PubMed  Google Scholar 

  30. Peng YF, Chen LK, Chou YH, et al. Hereditary hemorrhagic telangiectasia. Zhonghua Yi Xue Za Zhi (Taipei). 2002;65:614–8.

    Google Scholar 

  31. Caselitz M, Bahr MJ, Blerck JS, et al. Sonographic criterial for the diagnosis of hepatic involvement in hereditary hemorrhagic telangioectsia (HHT). Hepatology. 2003;37:1139–46.

    PubMed  Google Scholar 

  32. Buscarini E, Danesino C, Olivieri C, et al. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia—results of extensive screening. Ultraschall Med. 2004;25:348–55.

    PubMed  CAS  Google Scholar 

  33. Buscarini E, Danesino C, Plauchu H, et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol. 2004;30:1089–97.

    PubMed  Google Scholar 

  34. Freedom RM, Yoo SJ, Perrin D. The biological “scrabble” of pulmonary arteriovenous malformations: considerations in the setting of cavopulmonary surgery. Cardiol Young. 2004;14:417–37.

    PubMed  Google Scholar 

  35. Ocran K, Rickes S, Heukamp I, et al. Sonographic findings in hepatic involvement of hereditary haemorrhagic telangiectasia. Ultraschall Med. 2004;25:191–4.

    PubMed  CAS  Google Scholar 

  36. Han JK, Kim SH. Hepatic involvement in hereditary hemorrhagic telangiectasia. Korean J Hepatol. 2004;10:322–4.

    PubMed  Google Scholar 

  37. Geisthoff UW, Koester M, Fischinger J, et al. Rendu–Osler–Weber syndrome—a complex systemic disease. MMW Fortschr Med. 2004;146:33–5.

    PubMed  CAS  Google Scholar 

  38. Memeo M, Stabile Ianora AA, Scardapane A, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging. 2004;29:211–20.

    PubMed  CAS  Google Scholar 

  39. Ravard G, Soyer P, Boudiaf M, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr. 2004;28:488–95.

    PubMed  Google Scholar 

  40. Saluja S, White RI. Hereditary hemorrhagic telangiectasia of the liver: hyperperfusion with relative ischemia–poverty amidst plenty. Radiology. 2004;230:25–7.

    PubMed  Google Scholar 

  41. Folz BJ, Wollstein AC, Alfke H, et al. The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol. 2004;261:509–16.

    PubMed  Google Scholar 

  42. Ianora AA, Memeo M, Sabba C, et al. Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. Radiology. 2004;230:250–9.

    PubMed  Google Scholar 

  43. Dibilio D, Quaia E, Bertolotto M, et al. Color Doppler features of hepatic involvement in Rendu–Osler–Weber disease. Radiol Med. 2003;105:394–8.

    PubMed  Google Scholar 

  44. Thevenot T, Vanlemmens C, Di Martino V, et al. Liver transplantation for cardiac failure in patients with hereditary hemorrhagic telangiectasia. Liver Transpl. 2005;11:834–8.

    PubMed  Google Scholar 

  45. Cole SG, Begbie ME, Wallace GM, et al. New locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:77–82.

    Google Scholar 

  46. Memeo M, Stabile Ianora AA, Scardapane A, et al. Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs. Radiol Med. 2005;109:125–38.

    PubMed  CAS  Google Scholar 

  47. Willinek WA, Hadizadeh D, von Falkenhausen M, et al. Magnetic resonance (MR) imaging and MR angiography for evaluation and follow-up of hepatic artery banding in patients with hepatic involvement of hereditary hemorrhagic telangiectasia. Abdom Imaging. 2006;31:694–700.

    PubMed  CAS  Google Scholar 

  48. Buscarini E, Plauchu H, Garcia Tsao G, et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int. 2006;26:1040–6.

    PubMed  Google Scholar 

  49. Wu JS, Saluja S, Garcia-Tsao G, et al. Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. AJR Am J Roentgenol. 2006;187:W399–405.

    PubMed  Google Scholar 

  50. Giordano P, Nigro A, Lenato GM, et al. Screening for children from families with Rendu–Osler–Weber disease: from geneticist to clinician. J Thromb Haemost. 2006;4:1237–45.

    PubMed  CAS  Google Scholar 

  51. Memeo M, Scardapane A, Stabile Ianora AA, et al. Hereditary haemorrhagic teleangiectasia: diagnostic imaging of visceral involvement. Curr Pharm Des. 2006;12:1227–355.

    PubMed  CAS  Google Scholar 

  52. Lesca G, Olivieri C, Burnichon N, et al. Genotype–phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French–Italian HHT network. Genet Med. 2007;9:14–22.

    Google Scholar 

  53. González-Casas R, Trapero-Marugán M, Moreno-Otero R. Hepatic disease in hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber disease). Med Clin (Barc). 2007;129:629–31.

    Google Scholar 

  54. Shields HM, Shaffer K, O’farrell RP, et al. Gastrointestinal manifestations of dermatologic disorders. Clin Gastroenterol Hepatol. 2007;5:1010–7.

    PubMed  Google Scholar 

  55. Lin E, Stall L. Spectrum of biliary abnormalities in hepatic hereditary hemorrhagic telangiectasia: demonstration by multidetector computed tomography. Emerg Radiol. 2007;14:461–3.

    PubMed  Google Scholar 

  56. Brakensiek K, Frye-Boukhriss H, Mälzer M, et al. Detection of a significant association between mutations in the ACVRL 1 gene and hepatic involvementin German patients with hereditary hemorrhagic telangiectasia. Clin Genet. 2008;74:171–7.

    PubMed  CAS  Google Scholar 

  57. Gincul R, Lesca G, Gelas-Dore B, et al. Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent lver involvement and early cardiac consequences. Hepatology. 2008;48:1570–6.

    PubMed  Google Scholar 

  58. Sharathkumar AA, Shapiro A. Hereditary hemorrhagic telangiectasia. Haemophilia. 2008;14:1269–80.

    PubMed  CAS  Google Scholar 

  59. Torabi M, Hosseinzadeh K, Federle MP. CT of nonneoplastic hepatic vascular and perfusion disorders. Radiographics. 2008;28:1967–82.

    PubMed  Google Scholar 

  60. Garcia-Tsao G, Swanson KL. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: in search of predictors of significant disease. Hepatology. 2008;48:1377–9.

    PubMed  Google Scholar 

  61. Khalid SK, Garcia-Tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis. 2008;28:247–58.

    PubMed  Google Scholar 

  62. Buscarini E, Manfredi G, Zambelli A. Doppler ultrasonography for the diagnosis of liver vascular malformations in hereditary hemorrhagic telangiectasia. J Hepatol. 2008;49:658–9.

    PubMed  Google Scholar 

  63. Buscarini E, Gebel M, Ocran K, et al. Interobserver agreement in diagnosing liver involvement in hereditary hemorrhagic telangiectasia by Doppler ultrasound. Ultrasound Med Biol. 2008;34:718–25.

    PubMed  Google Scholar 

  64. Sabbà C, Pompili M. Review article: the hepatic manifestations of hereditary haemorrhagic telangiectasia. Aliment Pharmacol Ther. 2008;28:523–33.

    PubMed  Google Scholar 

  65. Memeo M, Scardapane A, De Blasi R, et al. Diagnostic imaging in the study of visceral involvement of hereditary haemorrhagic telangiectasia. Radiol Med. 2008;113:547–66.

    PubMed  CAS  Google Scholar 

  66. Buonamico P, Suppressa P, Lenato GM, et al. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color-Doppler vs multislice computed tomography study. J Hepatol. 2008;48:811–20.

    PubMed  Google Scholar 

  67. Siddiki H, Doherty MG, Fletcher JG, et al. Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. Radiographic. 2008;28:171–84.

    Google Scholar 

  68. Pierucci P, Murphy J, Henderson KJ, et al. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience. Chest. 2008;133:653–61.

    PubMed  Google Scholar 

  69. Carette MF, Nedelcu C, Tassart M, et al. Imaging of hereditary hemorrhagic telangiectasia. Cardiovasc Interv Radiol. 2009;32:745–57.

    Google Scholar 

  70. Faughnan ME, Granton JT, Young LH. The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J. 2009;33:1186–94.

    PubMed  CAS  Google Scholar 

  71. Brenard R, Chapaux X, Deltenre P, et al. Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary hemorrhagic telangiectasia: the Belgian registry based on 30 patients. Eur J Gastroenterol Hepatol. 2010;22:1253–9.

    PubMed  CAS  Google Scholar 

  72. Dupuis-Girod S, Chesnais A-L, Ginon I, et al. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation. Liver Transpl. 2010;16:340–7.

    PubMed  Google Scholar 

  73. Zarrabeitia R, Albinana V, Salcedo M, et al. A review on clinical management and pharmacological therapy on hereditary hemorrhagic telangiectasia (HHT). Curr Vasc Pharmacol. 2010;8:473–81.

    PubMed  CAS  Google Scholar 

  74. Olitsky SE. Hereditary hemorrhagic telangiectasia: diagnosis and management. Am Fam Physician. 2010;82:785–90.

    PubMed  Google Scholar 

  75. Lee M, Sze DY, Bonham CA, et al. Hepatic arteriovenous malformations from hereditary hemorrhagic telangiectasia: treatment with liver transplantation. Dig Dis Sci. 2010;55:3059–62.

    PubMed  Google Scholar 

  76. Brenard R, Chapaux X, Deltenre P, et al. Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. Eur J Gastroenterol Hepatol. 2010;22:1253–9.

    PubMed  CAS  Google Scholar 

  77. Piskorz MM, Waldbaum C, Volpacchio M, et al. Liver involvement in hereditary hemorrhagic telangiectasia. Acta Gastroenterol Latinoam. 2011;41:225–9.

    PubMed  Google Scholar 

  78. Senzolo M, Riggio O, Primignani M, Italian Association for the Study of the Liver (AISF) ad hoc. Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. Dig Liver Dis. 2011;43:503–14.

    PubMed  Google Scholar 

  79. Barral M, Sirol M, Placé V, et al. Hepatic and pancreatic involvement in hereditary hemorrhagic telangiectasia: quantitative and qualitative evaluation with 64-section CT in asymptomatic adult patients. Eur Radiol. 2012;22:161–70.

    PubMed  Google Scholar 

  80. Scardapane A, Stabile Ianora A, et al. Dynamic 4D MR angiography versus multislice CT angiography in the evaluation of vascular hepatic involvement in hereditary haemorrhagic telangiectasia. Radiol Med. 2012;117:29–45.

    PubMed  CAS  Google Scholar 

  81. Dupuis-Girod S, Ginon I, Saurin JC, et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA. 2012;307:948–55.

    PubMed  CAS  Google Scholar 

  82. Vlachou PA, Colak E, Koculym A, et al. Improvement of ischemic cholangiopathy in three patients with hereditary hemorrhagic telangiectasia following treatment with bevacizumab. J Hepatol. 2013;59:186–9.

    PubMed  CAS  Google Scholar 

  83. Stöwhas AC, Guldenschuh I, Andreisek G, et al. Hereditary hemorrhagic telangiectasia (Osler–Rendu–Weber syndrome). Praxis (Bern 1994). 2013;102:67–74.

    Google Scholar 

  84. Ginon I, Decullier E, Finet G, et al. Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences. Eur J Intern Med. 2013;24:e35–e3939.

    PubMed  Google Scholar 

  85. Sopeña B, Pérez-Rodríguez MT, Portela D, et al. High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. Eur J Intern Med. 2013;24:e30–e3434.

    PubMed  Google Scholar 

  86. Scardapane A, Ficco M, Sabbà C, et al. Hepatic nodular regenerative lesions in patients with hereditary haemorrhagic telangiectasia: computed tomography and magnetic resonance findings. Radiol Med. 2013;118:1–13.

    PubMed  CAS  Google Scholar 

  87. McCann TE, Scoutt LM, Gunabushanam G. Hepatic involvement of hereditary hemorrhagic telangiectasia: evaluation with ultrasound. Ultrasound Q. 2014;30:221–4.

    PubMed  Google Scholar 

  88. Moulinet T, Mohamed S, Deibener-Kaminsky J, et al. High prevalence of arterial aneurysms in hereditary hemorrhagic telangiectasia. Int J Cardiol. 2014;176:1414–6.

    PubMed  CAS  Google Scholar 

  89. Savale L, Sattler C, Sitbon O. Pulmonary hypertension in liver diseases. Presse Med. 2014;43:970–80.

    PubMed  Google Scholar 

  90. Coremans L, Van den Bossche B, Colle I. Hepatic involvement in hereditary hemorrhagic telangiectasia (HHT) or Rendu–Osler Weber syndrome. Acta Gastroenterol Belg. 2015;78:319–26.

    PubMed  CAS  Google Scholar 

  91. Courcoutsakis N, Peihaberis P, Erkotidou H, et al. Education and imaging. Hepatobiliary and pancreatic: role of CT angiography in the evaluation of liver involvement in Rendu–Osler–Weber syndrome. J Gastroenterol Hepatol. 2016;31:522. https://doi.org/10.1111/jgh.13162.

    Article  PubMed  CAS  Google Scholar 

  92. Jervis S, Skinner D. Screening for arteriovenous malformations in hereditary haemorrhagic telangiectasia. J Laryngol Otol. 2016;130:734–42.

    PubMed  CAS  Google Scholar 

  93. Cavel A, Bleuzen A, Bertrand P, et al. Comparison between Doppler ultrasonography and multiphase multidetector-row computed tomography in the detection of liver involvement in Rendu–Osler disease: an analysis of 62 patients. Diagn Interv Imaging. 2016;97:451–9.

    PubMed  CAS  Google Scholar 

  94. Martín-Llahí M, Albillos A, Bañares R, et al. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver. Gastroenterol Hepatol. 2017;40:538–80.

    PubMed  Google Scholar 

  95. Plowman RS, Javidan-Nejad C, Raptis CA, et al. Imaging of pregnancy-related vascular complications. Radiographics. 2017;37:1270–89. https://doi.org/10.1148/rg.2017160128.

    Article  PubMed  Google Scholar 

  96. Elsayes KM, Shaaban AM, Rothan SM, et al. A comprehensive approach to hepatic vascular disease. Radiographics. 2017;37:813–36.

    PubMed  Google Scholar 

  97. Giordano P, Francavilla M, Buonamico P, et al. Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2. Vasa. 2017;46:195–202.

    PubMed  Google Scholar 

  98. Healy L, Nicholls K, Gibson R, et al. Absence of renal phenotype in hereditary hemorrhagic telangiectasia. Intern Med J. 2018;48:1255–7.

    PubMed  Google Scholar 

  99. Hashmi SS, Haider N, Malik MI. Hereditary hemorrhagic telangiectasia—early childhood presentation with hepatic failure. J Coll Physicians Surg Pak. 2018;28:S195–S197197. https://doi.org/10.29271/jcpsp.2018.09.S195.

    Article  PubMed  Google Scholar 

  100. Buscarini E, Gandolfi S, Alicante S, et al. Liver involvement in hereditary hemorrhagic telangiectasia. Abdom Radiol (NY). 2018;43:1920–30. https://doi.org/10.1007/s00261-018-1671-4.

    Article  Google Scholar 

  101. Vilgrain V, Paradis V, Van Wettere M, et al. Benign and malignant hepatocellular lesions in patients with vascular liver diseases. Abdom Radiol (NY). 2018;43:1968–77. https://doi.org/10.1007/s00261-018-1502-7.

    Article  Google Scholar 

  102. Shovlin CL, Buscarini E, Kjeldsen AD, et al. European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary haemorrhagic telangiectasia. Orphanet J Rare Dis. 2018;13:136.

    PubMed  PubMed Central  Google Scholar 

  103. Schelker RC, Andorfer K, Putz F, et al. Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion propertiesby combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification. PLoS One. 2019;14:e0215178. https://doi.org/10.1371/journal.pone.0215178 (eCollection 2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  104. Tortora A, Riccioni ME, Gaetani E, et al. Rendu–Osler–Weber disease: a gastroenterologist’s perspective. Orphanet J Rare Dis. 2019;14:130. https://doi.org/10.1186/s13023-019-1107-4.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Hagen-Ansert SL. Vascular system. In: Hagen-Ansert SL, editor. Diagnostic sonography. St Louis: Elsevier, Mosby; 2018. p. 141–189.

    Google Scholar 

  106. Middleton WD, Erikson S, Melson GL. Perivascular color artifact: pathologic significance and appearance on color Doppler US image. Radioloy. 1989;171:647–52.

    CAS  Google Scholar 

  107. Mavrakis A, Demetris A, Ochoa ER, et al. Hereditary hemorrhagic telangiectasia of the liver complicated by ischemic bile duct necrosis and sepsis: case report and review of the literature. Dig Dis Sci. 2010;55:2113–7.

    PubMed  Google Scholar 

  108. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM FLAUS and ICUS. Ultrasound Med Biol. 2013;39:187–21010.

    PubMed  Google Scholar 

  109. Naganuma H, Ishida H, Ogawa M, et al. Visualization of draining vein in focal nodular hyperplasia by superb microvascular imaging: report of two cases. J Med Ultrason. 2017;44:323–8.

    Google Scholar 

  110. Flower M, Chern B. A case report of successful treatment of high-output heart failure secondary to hereditary hemorrhagic telangiectasia with bevacizumab. Oxf Med Case Rep. 2019. https://doi.org/10.1093/omcr/omz046.

    Article  Google Scholar 

  111. Maestraggi Q, Bouattour M, Toquet S, et al. Bevacizumab to treat cholangiopathy in hereditary hemorrhagic telangiectasia: be cautious: a case report. Medicine (Baltimore). 2015;94:e1966. https://doi.org/10.1097/MD.0000000000001966.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroko Naganuma.

Ethics declarations

Conflict of interest

We have no potential conflicts of interest.

Ethical statements

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).

Informed consent

Informed consent was obtained from all patients for being included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naganuma, H., Ishida, H., Kuroda, H. et al. Hereditary hemorrhagic telangiectasia: how to efficiently detect hepatic abnormalities using ultrasonography. J Med Ultrasonics 47, 421–433 (2020). https://doi.org/10.1007/s10396-020-01022-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-020-01022-w

Keywords

Navigation